Article
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
1 Dec 2017
Abstract excerpt
BACKGROUND: Docetaxel-based chemotherapy failure in advanced prostate carcinoma has partly been attributed to the resistance of prostate cancer (PC) cells to docetaxel-induced apoptosis. Hence, there is an urgent need to identify mechanisms of docetaxel chemoresistance and to develop new combination therapies. METHODS: miR-193a-5p level was evaluated by qPCR in prostate tissues and cell lines, and its expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
